Pharmaceutical Sciences Seminars - Fall 2018
| DATE | PRESENTER | INSTITUTION | TITLE / TYPE | TIME | LOCATION |
| 08/31/2018 | Steven A. Soper | University of Kansas | Precision Medicine Using Liquid Biopsies: A New Paradigm for Managing Cancer Diseases | Noon | PDD 1002 |
| 09/05/2018 and 09/06/2018 |
Biopharmaceutical Research & Development Symposium | See Schedule | Sorrell Events Center | ||
| 09/14/2018 | JinJun Shi | Harvard | Bioresponsive Nanotechnologies for RNA Delivery and Antioxidative Therapy | Noon | PDD 1002 |
| 09/20/2018 | Anil K. Sood | The University of Texas MD Anderson Cancer Center | Therapeutic Applications of Non-Coding RNAs | Noon | PDD 1002 |
| 09/28/2018 | Kelly Johnson/Pat Wortmann | UNMC | Laboratory Safety | Noon | PDD 1002 |
| 10/05/2018 | Santosh Aryal | Kansas State University | Cell Membrane Camouflage Therapeutic Nanoparticles: A Biomimetic Design to Fight Against Cancer | Noon | PDD 1002 |
| 10/11/2018 | Sharyn D. Baker | The Ohio State University | 20 years of Tyrosine Kinase Inhibitor Therapy in Cancer: A Pharmaceutical Perspective | Noon | PDD 1002 |
| 10/26/2018 | Rajagopal Ramesh | University of Oklahoma | To Target or Not To Target CancHUR | Noon | PDD 1002 |
| 11/09/2018 | Yon Rojanasakul | West Virginia University | Nanomaterial Carcinogenicity | Noon | PDD 1002 |
| 11/16/2018 | Bin Duan | UNMC | Noon | PDD 1002 | |
| 11/30/2018 | Students/Postdocs | UNMC | Noon | PDD 1002 | |
| 12/07/2018 | Ed Ezell | UNMC - NMR | Noon | PDD 1002 | |